|
|
Volumn 28, Issue 28, 2010, Pages
|
|
[18F]fluorodeoxyglucose positron emission tomography in the initial staging of squamous cell carcinoma of the head and neck: Promise, evidence, and reality
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
ADVANCED CANCER;
CANCER REGISTRY;
CANCER RISK;
CANCER STAGING;
CLINICAL ASSESSMENT;
COMPUTER ASSISTED TOMOGRAPHY;
DIAGNOSTIC ERROR;
DIAGNOSTIC TEST ACCURACY STUDY;
DISTANT METASTASIS;
HEAD AND NECK CARCINOMA;
HEAD AND NECK SQUAMOUS CELL CARCINOMA;
HIGH RISK POPULATION;
HUMAN;
LETTER;
MEDICAL DECISION MAKING;
MEDICAL SOCIETY;
OVERALL SURVIVAL;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
SQUAMOUS CELL CARCINOMA;
TREATMENT RESPONSE;
HEAD AND NECK TUMOR;
NOTE;
PATHOLOGY;
SCINTISCANNING;
SURVIVAL;
CARCINOMA, SQUAMOUS CELL;
FLUORODEOXYGLUCOSE F18;
HEAD AND NECK NEOPLASMS;
HUMANS;
NEOPLASM STAGING;
POSITRON-EMISSION TOMOGRAPHY;
PROSPECTIVE STUDIES;
RADIOPHARMACEUTICALS;
SURVIVAL ANALYSIS;
|
|
EID: 78049430622
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2010.29.6715 Document Type: Letter |
|
Times cited : (2)
|
|
References (8)
|
